Showing results (541-550 of 583) with videos related to

Sort By:
Pageof 59
Circulation|November 1, 1988
Effect of preoperative hemodynamic support on survival after cardiac transplantationJ B O'Connell, D G Renlund, J A Robinson, et al.
The Journal of Pediatrics|May 23, 2018
Racial and Ethnic Differences in the Prevalence of Congenital Cytomegalovirus InfectionKaren B Fowler, Shannon A Ross, Masako Shimamura, et al.
The Pediatric Infectious Disease Journal|May 15, 2015
Urine Collection Method for the Diagnosis of Congenital Cytomegalovirus InfectionShannon A Ross, Amina Ahmed, April L Palmer, et al.
The Journal of Infectious Diseases|May 7, 2014
Detection of congenital cytomegalovirus infection by real-time polymerase chain reaction analysis of saliva or urine specimensShannon A Ross, Amina Ahmed, April L Palmer, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 1, 1994
Cardiac transplantation: the Stanford experience in the cyclosporine eraG E Sarris, K A Moore, J S Schroeder, et al.
Journal of the American College of Cardiology|April 20, 2004
Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) studyJean L Rouleau, Ellen B Roecker, Michal Tendera, et al.
The New England Journal of Medicine|June 2, 2001
Effect of carvedilol on survival in severe chronic heart failureM Packer, A J Coats, M B Fowler, et al.
Circulation|December 1, 1996
Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA InvestigatorsM R Bristow, E M Gilbert, W T Abraham, et al.
European Journal of Heart Failure|February 28, 2004
NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP substudyFranz Hartmann, Milton Packer, Andrew J S Coats, et al.
Circulation|September 24, 2004
Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trialFranz Hartmann, Milton Packer, Andrew J S Coats, et al.
Pageof 59